Antipyretic, analgesic, anti-inflammatory

Antipyretic, analgesic, anti-inflammatory

Antipyretic, analgesic, anti-inflammatory

Antipyretic, analgesic, anti-inflammatory

Antipyretic, analgesic, anti-inflammatory

Antipyretic, analgesic, anti-inflammatory

Antipyretic, analgesic, anti-inflammatory

Antipyretic, analgesic, anti-inflammatory

Antipyretic, analgesic, anti-inflammatory

The second-generation sulfonylurea hypoglycemic drug selectively acts on pancreatic beta cells, promoting insulin secretion and increasing insulin release after ingesting glucose, thereby inhibiting liver glucose production and output; it reduces platelet aggregation and adhesion, and helps prevent and treat diabetic microangiopathy.

It has high antibacterial activity against aerobic Gram-positive cocci, such as Staphylococcus (including penicillin-resistant and methicillin-sensitive strains), hemolytic streptococci, viridans streptococci, and pneumococci. It also has good antibacterial effects on anaerobic bacteria. Most of the Bacteroides, Fusobacterium, Actinomyces, Peptococci, and Peptostreptococci are sensitive to this product. It acts on the 50S subunit of the ribosome of sensitive bacteria, preventing the extension of the peptide chain, thereby inhibiting the protein synthesis of bacterial cells. It is generally an antibacterial agent, but at high concentrations, it also has a bactericidal effect on certain bacteria.

Clearing away heat and detoxifying

Clearing away heat and detoxifying

Clearing away heat and detoxifying

Clearing away heat and detoxifying

Clearing away heat and detoxifying

Clearing away heat and detoxifying

Clearing away heat and detoxifying

Clearing away heat and detoxifying

Clearing away heat and detoxifying

Clearing away heat and detoxifying

Clearing away heat and detoxifying

A broad-spectrum antiviral drug that inhibits the growth of multiple viruses in vitro, including respiratory syncytial virus, influenza virus, hepatitis A virus, and adenovirus. After entering the virus-infected cells, the drug is rapidly phosphorylated, and its product acts as a competitive inhibitor of viral synthase, inhibiting inosine monophosphate dehydrogenase, influenza virus RNA polymerase, and mRNA guanosine transferase, thereby causing a reduction in intracellular guanosine triphosphate, impairing viral RNA and protein synthesis, and inhibiting viral replication and transmission. It may also have an immune effect and neutralizing antibody effect on respiratory syncytial virus.